Dr KONIEV Sasha

Fiche personne


coordonnées

Syndivia
650 Boulevard Gonthier d’Andernach
67400 ILLKIRCH

03 68 85 43 01

ok@syndivia.com

Territoire

Alsace

Statut

Chercheur

équipes/plateformes

Plateforme Syndivia

Recherche

Mots clés : Targeted cancer therapies,Antibody-Drug Conjugates

Publications


INA03, a potent transferrin-competitive antibody-drug conjugate against CD71, for a safer acute leukemia treatment.

Bratti M, Stubbs E, Kolodych S, Souchet H, Kelly L, Merlin J, Marchal M, Castellano R, Josselin E, Pasquer H, Benajiba L, Puissant A, Koniev O, Collette Y, Belanger C, Hermine O, Monteiro RC, Launay P

Mol Cancer Ther. 2024 04 20;:

Reinvestigation of the Automated Synthesis of Stoichiometrically Conjugated Antibodies to Access High Molecular Weight Payloads and Multiplexed Conjugation via an In-Solution Trans-Tagging Process.

Lehot V, Lidický O, Most J, Erb S, Dovgan I, Osypenko A, Koniev O, Kolodych S, Kotrchová L, Chaubet G, Cianférani S, Etrych T, Wagner A

ACS Omega. 2023 10 31;8(43):40508-40516

On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency.

Dovgan I, Ehkirch A, Lehot V, Kuhn I, Koniev O, Kolodych S, Hentz A, Ripoll M, Ursuegui S, Nothisen M, Cianférani S, Wagner A

Sci Rep. 2020 May 6;10(1):7691

Voir plus